Newsletter Signup | Community
Cancer Connect - Treatment of Stage II Melanoma
Cancer Connect - Treatment of In Situ & Stage 1 Melanoma
Keytruda® Continues to have Improved Survival Benefit Compared to Yervoy® in Advanced Melanoma.
Yervoy + Opdivo Improves Overall Survival in Advanced Melanoma; Average Survival May Exceed 4 Years
Biomarkers drive new drug development in melanoma
Keynote 054 clinical trial establishes Keytruda as standard treatment for stage III melanoma.
A new very active treatment option for Melaoma-Braftovi